AC Immune

News

Positive Ph1 results for AC Immune's NLRP3 inflammasome inhi...

AC Immune has announced positive interim results from its Ph 1 study of ACI-19764 – a NLRP3 inflammasome inhibitor targeting chronic inflammation.

News

AC Immune's chief executive Dr Andrea Pfeifer

AC Immune says Parkinson's drug slows progression

AC Immune's active immunotherapy study backs up the alpha-synuclein hypothesis in Parkinson's disease, after disappointments in earlier trials.

News

Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot

Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC Immune’s amyloid-targeting immunotherapy.

News

Roche ducks out of AC Immune Alzheimer's antibody alliance

After almost 18 years of collaboration, Roche’s Genentech unit has ended a collaboration with AC Immune on Alzheimer’s disease therapies, handing back rights to two antibo

News

Conceptual image of a head with cog gears as brain.

AC Immune tries to resurrect crenezumab with new data delve

In May, another amyloid targeting drug for Alzheimer's disease – AC Immune and Roche's crenezumab – missed the mark in another clinical trial and looked destined for the scrap heap like so

News

Closeup of X-ray photography of human brain

Another amyloid miss in Alzheimer's as Roche's crenezumab fa...

The litany of failed trials of amyloid-targeting drugs for Alzheimer's disease has added another verse, as Roche concedes that its crenezumab candidate was unable to slow cognitive decline

Positive Ph1 results for AC Immune's NLRP3 inflammasome inhi...

AC Immune says Parkinson's drug slows progression

Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot

Roche ducks out of AC Immune Alzheimer's antibody alliance

AC Immune tries to resurrect crenezumab with new data delve

Another amyloid miss in Alzheimer's as Roche's crenezumab fa...

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

AC Immune

Editor's Picks